American Journal of Ophthalmology
Volume 142, Issue 6 , Pages 961-969.e4 , December 2006

Vascular Endothelial Growth Factor Is a Critical Stimulus for Diabetic Macular Edema

,Accepted 29 June 2006.

References 

  1. Klein R. Retinopathy in a population-based study. Trans Am Ophthalmol Soc. 1992;90:561–594
  2. Moore J, Bagley S, Ireland G, et al. Three dimensional analysis of microaneurysms in the human diabetic retina. J Anat. 1999;194:89–100
  3. Nguyen QD, Shah SM, van Anden E, et al. Supplemental inspired oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci. 2003;45:617–624
  4. Ozaki H, Hayashi H, Vinores SA, et al. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res. 1997;64:505–517
  5. Derevjanik NL, Vinores SA, Xiao W-H, et al. Quantitative assessment of the integrity of the blood-retinal barrier in mice. Invest Ophthalmol Vis Sci. 2002;43:2462–2467
  6. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178–1181
  7. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113:325–332
  8. The Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema, ETDRS Report No. 1. Arch Ophthalmol. 1985;103:1644–1652
  9. Chan A, Duker JS, Ko TH, et al. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch Ophthalmol. 2006;124:193–198
  10. Campochiaro PA C99-PKC412-003 Study Group. Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. Invest Ophthalmol Vis Sci. 2004;45:922–931
  11. Macugen Diabetic Retinopathy Study Group. A phase II randomized double-masked study of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology. 2005;112:1747–1757

 Supported by the Innovative Grant Award from the Juvenile Diabetes Research Foundation; by a scholarship from the Scientific and Technological Research Council of Turkey (S.T.); and by a K23 Career Development Award (EY 13552) from the National Eye Institute (Q.D.N.). The study drug was provided by Genentech, Inc.Supplemental Material available at AJO.com.

PII: S0002-9394(06)00809-9

doi: 10.1016/j.ajo.2006.06.068

American Journal of Ophthalmology
Volume 142, Issue 6 , Pages 961-969.e4 , December 2006

Article Tools

* Image Usage & Resolution